Molecular Diagnostics
BDNF Risk Variant Linked to Brain Inflammation in RRMS Patients
Multiple sclerosis (MS) is a chronic inflammatory disease of the central nervous system (CNS) that is nowadays representing one of the main causes of disability in young people. The clinical course of MS is highly variable and reflects the complex pathogenesis characterized by inflammation and neurodegeneration already detectable in the initial stages of the disease. More...28 Mar 2022
Enzyme-Based Point-of-Care Test Could Rapidly Identify Stroke Patients upon Arrival at Hospital
Researchers at Cornell University (Ithaca, NY, USA) have developed a new test that could rapidly identify stroke patients upon arrival at the hospital, so that more patients could receive a CT scan and the clot-dissolving medicine tPA within the critical window. The researchers plan to develop this enzyme-based technology into a range of diagnostic tests that can be performed anywhere using a handheld device. Their initial research has shown that the test effectively diagnoses stroke and concussions. More...25 Mar 2022
New Antibody Test Diagnoses Multiple Sclerosis in 20 Minutes
Researchers at Mayo Clinic (Rochester, MN, USA) have validated a new antibody test to diagnose multiple sclerosis (MS) that measures kappa immunoglobulin free light chains in cerebrospinal fluid. The researchers conclude the test is a valid alternative to a commonly used test to detect oligoclonal bands in cerebrospinal fluid. More...25 Mar 2022
Cerebrospinal Fluid Liquid Biopsy for Diagnosis of Metastatic Breast Cancer
A liquid biopsy technique that detects cell-free tumor DNA (ctDNA) in the cerebrospinal fluid (CSF) offers the possibility for early and definitive diagnosis of leptomeningeal metastasis of breast and other cancers. More...23 Mar 2022
Gold Member
Collection and Transport System
PurSafe Plus®
Homocysteine Quality Control
Liquichek Homocysteine Control
Rapid Molecular Testing Device
FlashDetect Flash10
In Other News
Novel Painless Test Massively Simplifies Diagnosis of Allergies and Predicts Success of Immunotherapy
Genetic Overlap Found for Ovarian Cancer Subtypes and Endometriosis
Personalized Tumor-Informed Assay Helps Patients Get Ahead of Cancer
Worm-on-a-Chip Device Could Noninvasively Diagnose Early-Stage Cancer
Pediatric Cancer Sequencing Expands Relapse Treatment Options
Alpha-Synuclein Skin Deposits Characterize Parkinson’s Disease Patients
Blood Plasma Biomarkers Could Improve Diagnostic Tests for Alzheimer's Disease
Groundbreaking DNA Test Evaluates Biomarkers in 517 Cancer-Relevant Genes across 30 Types of Solid Tumors
Single Cell Characterization Acral Melanoma Identifies Novel Targets for Immunotherapy
New Test Could Help Diagnose Lyme Disease Sooner and Determine Treatment Efficacy
Expression, Microbiome Features Provide Pre-Treatment Lung Function Clues for Pediatric Patients
Next-Gen Graphene Biosensor Technology Enables Lab Quality Diagnostics of Infectious Diseases, Anytime, Anywhere
Two Circulating Biomarkers Predict Cardiovascular Disease Risk in Psoriasis Patients
Fecal Microbiome Signature Predicts Pancreatic Cancer Risk
Stem Cell Architecture Drives Myelodysplastic Syndrome Progression
Single Test for Over 50 Genetic Diseases Cuts Diagnosis from Decades to Days
Paper-Based Portable Diagnostic Platform Accurately Detects Mosquito-Borne Diseases Under Field Conditions
Low-Cost Multiplexed Electrochemical Biomarker Detection Platform to Be Commercialized in POC Diagnostics
Inherited Cancer Risk Detected in Significant Subset of Wilms Tumor Cases
'Fingerprint' Machine Learning Technique Identifies Different Bacteria in Seconds
Liquid Biopsy of Cerebrospinal Fluid for Diagnosis of Medulloblastoma
Single-Antigen Assays Increase Clinical Laboratory's Ability to Identify Acceptable Donors for Transplants
Prognostic Test Identifies High Risk and Low Risk Smoldering Multiple Myeloma Patients
Genetic Testing channel of LabMedica brings the latest in molecular genetics, cytogenetics, and epigenetics, and methods from PCR to FISH, and more.